OPERA 2025: Jennifer Stevenson Introducing the first member of the OPERA 2025 shortlist, Jennifer Stevenson, lead pharmacist for older adults at Guy’s and St Thomas’ NHS Foundation Trust, and an honorary senior lecturer at King’s College London.…
NHS App to be used to recruit patients for clinical trials The Department of Health and Social Care said it is particularly encouraging underrepresented groups, such as people from ethnic minority backgrounds, to sign up to trials.…
What do recent reviews of research literature tell us about the evolving role of pharmacy and pharmaceutical sciences? The pick of recent review papers from the RPS chief scientist’s office.…
Antibiotic could help tackle drug-resistant gonorrhoea, study results suggest Researchers found that gepotidacin was as effective as the current recommended first-line therapy for gonorrhoea.…
Patients involved in design of fewer than one-fifth of published trials, research shows For articles reporting on randomised controlled trials, published between 2015 and 2023, the researchers found that 18% included patient and public involvement.…
Pharmacists included in latest cohort of NIHR senior investigators The National Institute for Health and Care Research's senior investigators will receive discretionary funding of £20,000 per year of appointment to support research activities, “while they take on a senior leadership role within NIHR”.…
Two-thirds of cholesterol point-of-care tests fail to meet standards, researchers warn Authors of a literature review found that only two out of six point-of-care tests “mostly met” necessary standards for use in the NHS Health Check programme.…
Testosterone in menopause: a review of the evidence and prescribing practice A closer look at the evidence base around testosterone prescribing for women with menopause, analysing the impact of regional formularies and the surge in demand in recent years.…
Exploring research methods used in pharmacy research The pick of recent academic papers from the Royal Pharmaceutical Society's chief scientist’s office.…
New class of anticoagulant found to ‘overwhelmingly’ reduce bleeding events in patients with atrial fibrillation Experts say the results of this “exciting” two-year study of abelacimab “add to the growing evidence that inhibition of factor XI may preferentially impact thrombosis over haemostasis”.…
